Prevalence and outcomes of DKA in type 1 and type 2 DM patients treated and not treated with SGLT-2 inhibitors.

Diabet Med · 2026 · PMC12982663 · PMID 41673901

Europe PMC DOI

hedged sentences

0.0630

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

did not reach statistical significancep = 0.063so close (0.05 < p ≤ 0.1)

Over the 12‐month follow‐up, hypoglycaemia remained numerically higher in T1DM (8.82 ± 144.27) compared with T2DM (1.08 ± 9.88), although the difference did not reach statistical significance ( p = 0.063).

also in 111,027 other papers

borderline significancep = 0.066so close (0.05 < p ≤ 0.1)

In T1DM, 1‐year mortality showed borderline significance between SGLT2 users and non‐users (0% vs. 15.1%, p = 0.066), although the small number of SGLT2‐treated T1DM patients limits interpretation. 3.4.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.